Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits.
about
Vaccines for preventing typhoid feverVaccines for preventing typhoid feverOverview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®)Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909Vaccination against typhoid fever: present statusReview of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.Specific and cross-reactive plasmablast response in humans after primary and secondary immunization with Vi capsular polysaccharide typhoid vaccine.Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.Commensal Streptococcus mitis is a unique vector for oral mucosal vaccination.Exploring Host-Commensal Interactions in the Respiratory Tract.Noninvasive vaccination against infectious diseases.
P2860
Q24201238-A2A00FBE-1EDD-4D00-A6E3-77812CC980E3Q24244406-773EAF04-9553-4A42-B670-4A5EEDB69D28Q33690625-C7889885-8184-4E55-A1B0-33098003EB87Q34007802-63EE0B3B-7FDE-424E-86E5-14FCDDCBC22FQ36794750-C068F05E-E74B-498F-BEAC-F1BED28D925DQ38600784-580B0D99-3E43-48FD-B51A-DBBBC1E33A43Q40147988-594AC424-2781-433D-8886-B76A9194FC1DQ40222613-7D24D493-1424-424D-92AF-D0CAF0D3ED9DQ41592018-F91ACAB5-7E80-49BB-A960-9DF5DB598E86Q47641823-F486BB7B-57D4-4C65-9C63-5749285F27B8Q52602778-25DDC230-56B3-41D9-9674-47FBFAC497FE
P2860
Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Clinical and immunological res ...... in two groups of 30 recruits.
@en
type
label
Clinical and immunological res ...... in two groups of 30 recruits.
@en
prefLabel
Clinical and immunological res ...... in two groups of 30 recruits.
@en
P2093
P1433
P1476
Clinical and immunological res ...... s in two groups of 30 recruits
@en
P2093
A Fattorossi
P M Matricardi
P304
P356
10.1016/0264-410X(93)90237-R
P407
P577
1993-01-01T00:00:00Z